Nachrichten zur Emergent Biosolutions Inc. Aktie

Emergent (EBS) Q1 2026 Earnings Transcript

Image source: The Motley Fool.DATEThursday, April 30, 2026 at 5 p.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Joseph PapaExecutive…

Emergent BioSolutions Inc. (EBS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

…

Emergent BioSolutions (EBS) Earnings Transcript

Image source: The Motley Fool.DateWednesday, Oct. 29, 2025, at 5 p.m. ETCall participantsPresident and Chief Executive Officer — Joseph C.…

Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call Transcript

…

Emergent BioSolutions stock rises on government contract modification By Investing.com

Emergent BioSolutions stock rises on government contract modification…

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts

GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has…

Emergent BioSolutions: Strategic Turnaround Proving Tricky, But Im Still Hopeful

…

Emergent BioSolutions Announces Addition to Russell 3000® Index

GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the Company will…

Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions

BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions are part of the Zacks Screen of the Week…

Emergent BioSolutions Aktie: Stehen wir vor Schwierigkeiten?

Der Pharmakonzern trennt sich für 36,5 Millionen Dollar von seiner problembehafteten Produktionsstätte, während Analysten trotz Kursrückgang optimistisch bleiben. Emergent BioSolutions…

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

GAITHERSBURG, Md., March 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed…

Emergent BioSolutions (EBS) Q4 2024 Earnings Call Transcript

EBS earnings call for the period ending December 31, 2024.…

Emergent BioSolutions Inc. (EBS) Q4 2024 Earnings Call Transcript

…

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

GAITHERSBURG, Md., March 03, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…

Emergent Biosolutions Q4 2024 Earnings Preview

…

Emergent BioSolutions: Fokus auf Mpox und die Opioid-Krise

Emergent BioSolutions ist ein US-amerikanisches Biopharmaunternehmen, das sich auf die Entwicklung und Produktion von Impfstoffen, Antitoxinen und Biodefense-Produkten spezialisiert hat.…

Emergent BioSolutions: Stock Is A Likely Winner In 2025

…

Why Emergent BioSolutions Stock Blasted Higher Today

An analyst initiated coverage of Emergent BioSolutions (NYSE: EBS) stock as the last trading week of 2024 kicked off, and…

Emergent BioSolutions receives $50 million contract option from BARDA

…

Why Emergent BioSciences Stock Plummeted Today

Emergent BioSolutions (NYSE: EBS) saw its shares tumble on Tuesday, due to news of a share sell-off. The vaccine maker…

Emergent BioSolutions Aktie legt kräftig zu - CEO Joe Papa sieht profitables Wachstum - Kaufen!

Kulmbach (www.aktiencheck.de) - Emergent BioSolutions-Aktienanalyse von "Der Aktionär": Michael Diertl vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Emergent BioSolutions Inc.…

Emergent BioSolutions: Akien-Report-Tipp springt zweistellig an

Einen Kurssprung von rund 20 Prozent hat Emergent BioSolutions am Donnerstag hingelegt. Der Grund dafür waren deutlich besser als erwartete…

Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript

EBS earnings call for the period ending September 30, 2024.…

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic

GAITHERSBURG, Md., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) remains committed to supporting widespread…

Emergent BioSolutions Aktie: Kursrutsch trotz Erholungsversuchen

Die Aktie von Emergent BioSolutions verzeichnete in den letzten Wochen einen deutlichen Kursrückgang. Trotz zwischenzeitlicher Erholungsversuche notiert der Titel aktuell…

Emergent BioSolutions Aktie: Erholung nach starkem Kurseinbruch

Der US-Impfstoffhersteller Emergent BioSolutions verzeichnet eine bemerkenswerte Erholung an der Börse. Nach einem dramatischen Kurssturz im vergangenen Jahr konnte die…

Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola

GAITHERSBURG, Md., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded…

OHA is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing

New York, New York, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”) served as Administrative Agent…

Emergent BioSolutions: Unbekannter Lebensretter

Der Fentanyl-Missbrauch ist in den USA in den letzten Jahren zu einem riesigen Problem geworden. Eine Lösung dafür gibt es…

Emergent BioSolutions: Unbekannter Lebensretter

Der Fentanyl-Missbrauch ist in den USA in den letzten Jahren zu einem riesigen Problem geworden. Eine Lösung dafür gibt es…

Emergent BioSolutions: Positive News von der FDA - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Emergent BioSolutions-Aktienanalyse von "Der Aktionär": Michael Diertl vom Anlegermagazin "Der Aktionär" rät weiterhin zum Kauf der Aktie von…

Emergent BioSolutions: FDA sorgt für Blitzstart

In der dieswöchigen Ausgabe 36/24 hat DER AKTIONÄR zum Kauf der Biotech-Aktie Emergent Biosolutions geraten.…

Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals

GAITHERSBURG, Md., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has completed the…

Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa

GAITHERSBURG, Md., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced it is proactively working…

Emergent Leads Mpox-Tied Stock Gains as Investors Await Approval

Emergent BioSolutions Inc. led an advance in the stocks of companies working on vaccines and antiviral products this week as…

Why Emergent BioSolutions Stock Is Skyrocketing Today

Concerns about the mpox outbreak are causing Emergent BioSolutions shares to jump.…

Emergent BioSolutions (EBS) Q2 2024 Earnings Call Transcript

EBS earnings call for the period ending June 30, 2024.…

Emergent BioSolutions Inc. (EBS) Q2 2024 Earnings Call Transcript

…

Emergent BioSolutions plunges 37% on Q2 EPS miss, wider projected 2024 net loss

…

Emergent BioSolutions Inc. 2024 Q2 - Results - Earnings Call Presentation

…

Emergent BioSolutions Reports Second Quarter 2024 Financial Results

GAITHERSBURG, Md., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…

SERB Pharmaceuticals strengthens leadership in medical countermeasures with the global acquisition of RSDL® (Reactive Skin Decontamination Lotion) kit for $75 million

Philadelphia, PA, July 31, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the…

Emergent BioSolutions Launches Opioid Emergency Preparedness ‘Lay, Spray, Stay’ Public Education Campaign Starring Pro Football Hall of Famer Emmitt Smith

GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of…

Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day

GAITHERSBURG, Md., June 06, 2024 (GLOBE NEWSWIRE) -- In recognition of National Naloxone Awareness Day, Emergent BioSolutions Inc.…

dpa-AFX ProFeed